Acquired cystic disease-associated renal tumors: An immunohistochemical and fluorescence in situ hybridization study

Modern Pathology

Volumn 19, Issue 6, 2006, Pages 780-787

  Cossu Rocca, Paolo ^a,b   Eble, John N ^a   Zhang, Shaobo ^a   Martignoni, Guido ^c   Brunelli, Matteo ^c   Cheng, Liang ^a,d  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acquired cystic disease of kidney; Calcium oxalate; Cytogenetics; End stage renal disease; Fluorescence in situ hybridization (FISH); Kidney tumors

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CALCIUM OXALATE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN; PROTEIN CAM5.2; UNCLASSIFIED DRUG; VIMENTIN;

ACINAR CELL; ADULT; ARTICLE; CELL STRUCTURE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 6; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOPLASM; DISEASE ASSOCIATION; EOSINOPHIL; EPITHELIUM; EPITHELIUM TUMOR; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; STAINING;

ADENOCARCINOMA; ADULT; ANEUPLOIDY; CHROMOSOMES, HUMAN, 1-3; CHROMOSOMES, HUMAN, PAIR 6; DNA, NEOPLASM; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY DISEASES, CYSTIC; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 33646859683     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800604     Document Type: Article

References (33)

1. Denton MD, Magee CC, Ovuworie C, et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 2002;61:2201-2209.
2. Truong LD, Krishnan B, Cao JT, et al. Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis 1995;26:1-12.
3. Truong LD, Choi YJ, Shen SS, et al. Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol 2003;10:135-159.
4. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 1993;22:135-139.
5. Gronwald J, Baur AS, Holtgreve-Grez H, et al. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization. J Pathol 1999;187:308-312.
6. Hughson MD, Buchwald D, Fox M. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med 1986;110:592-601.
7. Ikeda R, Tanaka T, Moriyama MT, et al. Proliferative activity of renal cell carcinoma associated with acquired cystic disease of the kidney: comparison with typical renal cell carcinoma. Hum Pathol 2002;33:230-235.
8. Khurana KK, Truong LD, Verani RR. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma. Mod Pathol 1998;11:339-346.
9. Konda R, Sato H, Hatafuku F, et al. Expression of hepatocyte growth factor and its receptor C-met in acquired renal cystic disease associated with renal cell carcinoma. J Urol 2004;171:2166-2170.
10. Peces R, Martinez-Ara J, Miguel JL, et al. Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation. Nephrol Dial Transplant 2004;19:2789-2796.
11. Rioux-Leclercq NC, Epstein JI. Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney. Arch Pathol Lab Med 2003;127:E89-E92.
12. Hughson MD, Bigler S, Dickman K, et al. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification. Mod Pathol 1999;12:301-309.
13. Tickoo SK, de Peralta-Venturina MN, Salama M, et al. Spectrum of epithelial tumors in end stage renal disease (ESRD): emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Lab Invest 2003;83:173A.
14. Sule N, Yakupoglu U, Shen SS, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 2005;29:443-451.
15. Eble JN, Sauter G, Epstein JI, et al. Tumours of the Kidney World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press: Lyon, 2004.
16. Brunelli M, Eble JN, Zhang S, et al. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 2005;18:161-169.
17. Kuroda N, Toi M, Hiroi M, et al. Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003;18:165-171.
18. Kuroda N, Toi M, Hiroi M, et al. Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003;18:935-942.
19. Schwerdtle RF, Storkel S, Neuhaus C, et al. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma. Cancer Res 1996;56:2927-2930.
20. Fuzesi L, Frank D, Nguyen C, et al. Losses of 1p and chromosome 14 in renal oncocytomas. Cancer Genet Cytogenet 2005;160:120-125.
21. Cossu-Rocca P, Zhang S, Roth LM, et al. Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis. Mod Pathol 2006;19:611-615.
22. Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006;19:488-493.
23. Kernek KM, Brunelli M, Ulbright TM, et al. Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors. Mod Pathol 2004;17:1309-1313.
24. Brunelli M, Eble JN, Zhang S, et al. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod Pathol 2003;16:1060-1063.
25. Brunelli M, Eble JN, Zhang S, et al. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod Pathol 2003;16:1053-1059.
26. Hughson MD, Meloni AM, Silva FG, et al. Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: cytogenetic and molecular genetic findings. Cancer Genet Cytogenet 1996;89:65-68.
27. Hughson MD, Schmidt L, Zbar B, et al. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J Am Soc Nephrol 1996;7:2461-2468.
28. Dry SM, Renshaw AA. Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma: report of two cases. Arch Pathol Lab Med 1998;122:260-261.
29. Sant GR, Ucci Jr AA. Acquired renal cystic disease and adenocarcinoma following renal transplantation - a current urologic perspective. Urol Int 1998;60:108-112.
30. Cheuk W, Lo ES, Chan AK, et al. Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. Hum Pathol 2002;33:761-765.
31. Yoshida M, Yao M, Ishikawa I, et al. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney. Genes Chromosomes Cancer 2002;35:359-364.
32. Ishikawa I, Shikura N, Ozaki M. Papillary renal cell carcinoma with numeric changes of chromosomes in a long-term hemodialysis patient: a karyotype analysis. Am J Kidney Dis 1993;21:553-556.
33. O'Reilly KC, Tickoo SK, Amin MB, et al. Renal cell tumors arising in end stage renal disease (ESRD): a karyotypic study with fluorescent-in-situ- hybridization (FISH). Mod Pathol 2005;18:156A.